Skip to content

Hypergraph is more powerful. Transform unstructured text into structured knowledge with LLMs. Graphs, hypergraphs, and spatio-temporal extractions — with one command.

2.8 KB
Raw Blame

Pathology Examination Report

Basic Information

  • Pathology Number: 2026-02001
  • Patient Name: Li Si (Susan Lee)
  • Gender: Female
  • Age: 58 years old
  • Department: Breast Surgery
  • Submission Date: February 15, 2026
  • Report Date: February 20, 2026

Specimen Information

  • Specimen Type: Right breast modified radical mastectomy specimen
  • Specimen Size: 20cm×15cm×5cm
  • Tumor Location: Upper outer quadrant of right breast
  • Tumor Size: 3.5cm×2.5cm×2.0cm
  • Margin Status: No cancer tissue found in superior, inferior, medial, lateral, or basal margins

Histological Examination

Gross Examination

  • Tumor Morphology: Irregular shape, hard texture, unclear borders
  • Cut Surface Features: Grayish-white, fish-flesh appearance, with necrosis
  • Surrounding Tissue: Cancer infiltration visible in adipose tissue

Microscopic Examination

  • Histological Type: Invasive ductal carcinoma, no special type
  • Histological Grade: Grade II (Bloom-Richardson grading)
  • Mitotic Figures: 10/10HPF
  • Necrosis: Focal necrosis visible
  • Vascular Invasion: Lymphatic invasion present, no vascular invasion
  • Perineural Invasion: No perineural invasion

Immunohistochemistry Examination

Routine Immunohistochemistry

  • ER: (+, 90%)
  • PR: (+, 70%)
  • HER2: (2+)
  • Ki-67: (+, 30%)
  • E-cadherin: (+)
  • P120: (membrane +)
  • CK5/6: (-)
  • EGFR: (-)

FISH Testing

  • HER2 Gene Amplification: Positive (HER2/CEP17 ratio = 3.2)

Molecular Testing

Genetic Testing

  • BRCA1: Wild type
  • BRCA2: Wild type
  • PIK3CA: E545K mutation
  • TP53: R273H mutation
  • ERBB2: No mutation

Lymph Node Examination

  • Axillary Lymph Nodes: 20 nodes, 3 with cancer metastasis
  • Sentinel Lymph Nodes: 2 nodes, 1 with cancer metastasis
  • Internal Mammary Lymph Nodes: 0 nodes, no cancer metastasis

TNM Staging

  • T Stage: T2 (tumor maximum diameter >2cm and ≤5cm)
  • N Stage: N1 (1-3 axillary lymph node metastases)
  • M Stage: M0 (no distant metastasis)
  • Pathological Stage: pT2N1M0, Stage IIB

Other Examinations

  • Intracapsular Venous Tumor Thrombus: Positive
  • Perineural Invasion: Negative
  • Skin Invasion: Negative
  • Pectoralis Fascia Invasion: Negative

Pathological Diagnosis

Right breast invasive ductal carcinoma, no special type, Grade II, pT2N1M0, Stage IIB. IHC: ER (+, 90%), PR (+, 70%), HER2 (2+, FISH positive), Ki-67 (+, 30%). Molecular testing: PIK3CA E545K mutation, TP53 R273H mutation, BRCA1/2 wild type. Axillary lymph node metastasis (3/20), sentinel lymph node metastasis (1/2).

Remarks

  1. Comprehensive judgment recommended in combination with clinical and other examination results
  2. HER2-targeted therapy recommended